主角治疗公司
US ˙ NasdaqGM ˙ US74366E1029

介绍

本页面提供了有关 Dinesh V Ph D Patel 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Dinesh V Ph D Patel已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:PTGX / Protagonist Therapeutics, Inc. President and CEO, Director 520,603
如何解读这些图表

以下图表显示了在Dinesh V Ph D Patel进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

PTGX / Protagonist Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 PTGX / Protagonist Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
2019-12-03 PTGX PATEL DINESH V PH D 10,000 5.5500 10,000 5.5500 55,500 363 24.1600 186,100 335.32
2019-12-03 PTGX PATEL DINESH V PH D 20,000 5.6500 20,000 5.6500 113,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PTGX / Protagonist Therapeutics, Inc. Insider Trades
PTGX / Protagonist Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 PTGX / Protagonist Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2025-07-25 PTGX PATEL DINESH V PH D 10,415 54.7800 10,415 54.7800 570,534 13 50.9600 -39,785 -6.97
2025-07-23 PTGX PATEL DINESH V PH D 17,520 54.7900 17,520 54.7900 959,921
2025-07-22 PTGX PATEL DINESH V PH D 22,065 55.0500 22,065 55.0500 1,214,678
2025-07-21 PTGX PATEL DINESH V PH D 12,859 54.8600 12,859 54.8600 705,445
2025-02-19 PTGX PATEL DINESH V PH D 5,359 38.1800 5,359 38.1800 204,607
2024-11-26 PTGX PATEL DINESH V PH D 21,480 46.2500 21,480 46.2500 993,450
2024-11-25 PTGX PATEL DINESH V PH D 78,520 46.9600 78,520 46.9600 3,687,299
2021-12-21 PTGX PATEL DINESH V PH D 15,000 32.1447 15,000 32.1447 482,170
2019-08-06 PTGX PATEL DINESH V PH D 10,792 8.8524 10,792 8.8524 95,535
2019-03-01 PTGX PATEL DINESH V PH D 2,183 8.0300 2,183 8.0300 17,529
2019-02-06 PTGX PATEL DINESH V PH D 777 8.0981 777 8.0981 6,292
2019-02-06 PTGX PATEL DINESH V PH D 10,132 7.7100 10,132 7.7100 78,118

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PTGX / Protagonist Therapeutics, Inc. Insider Trades
内幕交易历史

该表格显示了由 Dinesh V Ph D Patel 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-07-28 2025-07-25 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -10,415 520,603 -1.96 54.78 -570,534 28,518,632
2025-07-23 2025-07-23 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -17,520 531,018 -3.19 54.79 -959,921 29,094,476
2025-07-23 2025-07-22 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -22,065 548,538 -3.87 55.05 -1,214,678 30,197,017
2025-07-23 2025-07-21 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -12,859 570,603 -2.20 54.86 -705,445 31,303,281
2025-07-23 2025-07-21 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 25,000 583,462 4.48
2025-07-18 2025-07-16 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -5,000 558,462 -0.89
2025-06-17 2025-06-16 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -685 562,905 -0.12
2025-06-17 2025-06-13 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -670 563,590 -0.12
2025-03-05 2025-03-05 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 24,000 564,260 4.44 4.21 101,040 2,375,535
2025-02-20 2025-02-19 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -5,359 540,260 -0.98 38.18 -204,607 20,627,127
2025-01-17 2025-01-15 4 PTGX Protagonist Therapeutics, Inc
Common Stock
F - Taxes -12,636 545,619 -2.26
2025-01-06 2025-01-02 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 149,800 558,255 36.67
2024-11-27 2024-11-26 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -21,480 408,455 -5.00 46.25 -993,450 18,891,044
2024-11-27 2024-11-25 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 1,727 429,935 0.40 21.58 37,269 9,277,997
2024-11-27 2024-11-25 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -7,000 428,208 -1.61
2024-11-27 2024-11-25 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -78,520 435,208 -15.28 46.96 -3,687,299 20,437,368
2024-11-21 2024-11-19 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -1,000 513,415 -0.19
2024-06-17 2024-06-13 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -1,000 514,415 -0.19
2024-06-11 2024-06-07 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -35,000 515,415 -6.36 35.19 -1,231,650 18,137,454
2024-04-02 2024-04-01 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -25,000 549,590 -4.35 28.31 -707,750 15,558,893
2024-03-01 2024-03-01 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -30,000 574,590 -4.96 31.62 -948,600 18,168,536
2024-02-28 2024-02-26 4 PTGX Protagonist Therapeutics, Inc
Common Stock
F - Taxes -10,915 604,590 -1.77 29.53 -322,320 17,853,543
2024-02-20 2024-02-15 4 PTGX Protagonist Therapeutics, Inc
Common Stock
F - Taxes -3,717 615,505 -0.60 28.23 -104,931 17,375,706
2024-01-04 2024-01-02 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 84,875 619,222 15.88
2023-12-15 2023-12-13 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -75,000 534,347 -12.31 20.08 -1,506,000 10,729,688
2023-10-19 2023-10-18 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 6,000 609,347 0.99 4.21 25,260 2,565,351
2023-06-02 2023-05-31 4 PTGX Protagonist Therapeutics, Inc
Common Stock
F - Taxes -12,165 602,946 -1.98 26.07 -317,142 15,718,802
2023-06-02 2023-05-31 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 30,000 615,111 5.13
2023-06-02 2023-02-22 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -10,000 583,448 -1.69
2023-01-18 2022-12-28 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -3,116 598,096 -0.52
2023-01-18 2022-05-04 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -3,000 581,048 -0.51
2022-08-24 2022-08-23 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 20,000 604,048 3.42 4.21 84,200 2,543,042
2022-05-04 2022-05-04 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -15,742 80,000 -16.44
2022-05-04 2022-05-04 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 15,742 584,048 2.77 4.21 66,274 2,458,842
2022-04-26 2022-04-26 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -30,000 95,742 -23.86
2022-04-26 2022-04-26 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 30,000 568,306 5.57 4.21 126,300 2,392,568
2022-04-14 2022-04-14 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -34,087 0 -100.00
2022-04-14 2022-04-14 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 34,087 537,847 6.77 1.89 64,424 1,016,531
2022-03-02 2022-02-28 4 PTGX Protagonist Therapeutics, Inc
Common Stock
F - Taxes -4,648 503,760 -0.91 24.28 -112,853 12,231,293
2022-02-17 2022-02-15 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 187,500 187,500
2022-02-17 2022-02-15 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 31,250 508,408 6.55
2021-12-23 2021-12-21 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -15,000 477,158 -3.05 32.14 -482,170 15,338,101
2021-09-21 2021-09-21 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -40,000 125,742 -24.13
2021-09-21 2021-09-21 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 40,000 492,158 8.85 4.21 168,400 2,071,985
2021-02-26 2021-02-26 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 225,000 225,000
2021-02-26 2021-02-26 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 25,000 451,144 5.87
2021-01-20 2021-01-19 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -13,000 165,742 -7.27
2021-01-20 2021-01-19 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -24,846 426,144 -5.51 24.60 -611,105 10,481,310
2021-01-20 2021-01-19 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 13,000 450,990 2.97 4.21 54,730 1,898,668
2020-05-01 2020-04-29 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -2,000 437,990 -0.45
2020-03-23 2020-03-20 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -10,000 34,087 -22.68
2020-03-23 2020-03-20 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 10,000 439,990 2.33 1.89 18,900 831,581
2020-03-13 2020-03-12 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -18,344 0 -100.00
2020-03-13 2020-03-12 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 18,344 429,990 4.46 1.16 21,279 498,788
2020-02-28 2020-02-28 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 235,000 235,000
2019-12-03 2019-12-03 4 PTGX Protagonist Therapeutics, Inc
Common Stock
P - Purchase 20,000 409,824 5.13 5.65 113,000 2,315,506
2019-12-03 2019-12-03 4 PTGX Protagonist Therapeutics, Inc
Common Stock
P - Purchase 10,000 389,824 2.63 5.55 55,500 2,163,523
2019-11-27 2019-11-26 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -4,000 18,343 -17.90
2019-11-27 2019-11-26 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 4,000 379,824 1.06 1.16 4,640 440,596
2019-08-08 2019-08-06 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -10,792 374,792 -2.80 8.85 -95,535 3,317,809
2019-03-04 2019-03-01 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -2,183 383,831 -0.57 8.03 -17,529 3,082,163
2019-03-04 2019-02-28 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 172,500 172,500
2019-03-04 2019-02-28 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 28,750 386,014 8.05
2019-02-08 2019-02-06 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -10,132 357,264 -2.76 7.71 -78,118 2,754,505
2019-02-08 2019-02-06 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale -777 367,396 -0.21 8.10 -6,292 2,975,210
2019-01-14 2019-01-11 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -22,344 22,343 -50.00
2019-01-14 2019-01-11 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 22,344 368,173 6.46 1.16 25,919 427,081
2018-08-17 2018-08-15 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 54,700 54,700
2018-08-17 2018-08-15 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 82,050 345,829 31.11
2018-07-13 2018-07-12 4 PTGX Protagonist Therapeutics, Inc
Common Stock
G - Gift -2,000 263,779 -0.75
2018-05-11 2018-05-10 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -13,516 44,687 -23.22
2018-05-11 2018-05-10 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 13,516 265,779 5.36 1.16 15,679 308,304
2018-04-03 2018-04-02 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -20,000 58,203 -25.57
2018-04-03 2018-04-02 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 20,000 252,263 8.61 1.16 23,200 292,625
2018-03-28 2018-03-26 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -11,298 0 -100.00
2018-03-28 2018-03-26 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 11,298 232,263 5.11 0.87 9,829 202,069
2018-03-02 2018-02-28 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 150,000 150,000
2018-03-02 2018-02-28 4 PTGX Protagonist Therapeutics, Inc
Common Stock
A - Award 25,000 219,259 12.87
2017-12-21 2017-12-21 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -8,210 44,087 -15.70
2017-12-21 2017-12-21 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -8,210 190,437 -4.13 19.56 -160,570 3,724,529
2017-12-21 2017-12-21 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 8,210 198,647 4.31 1.89 15,517 375,443
2017-12-20 2017-12-20 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -1,790 52,297 -3.31
2017-12-20 2017-12-20 4 PTGX Protagonist Therapeutics, Inc
Common Stock
S - Sale X -1,790 190,437 -0.93 19.55 -34,987 3,722,282
2017-12-20 2017-12-20 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 1,790 192,227 0.94 1.89 3,383 363,309
2017-05-10 2017-05-09 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -19,099 78,203 -19.63
2017-05-10 2017-05-09 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 19,099 190,437 11.15 1.16 22,155 220,907
2017-04-07 2017-04-06 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -20,000 97,302 -17.05
2017-04-07 2017-04-06 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 20,000 171,338 13.22 1.16 23,200 198,752
2017-03-13 2017-03-10 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -16,362 11,297 -59.16
2017-03-13 2017-03-10 4 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 16,362 151,338 12.12 0.87 14,235 131,664
2017-02-03 2016-12-22 5 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
M - Exercise -3,000 27,659 -9.79
2017-02-03 2016-12-22 5 PTGX Protagonist Therapeutics, Inc
Common Stock
M - Exercise 3,000 134,976 2.27 0.87 2,610 117,429
2016-10-13 2016-10-11 4 PTGX Protagonist Therapeutics, Inc
Stock Option (right to buy)
A - Award 320,000 320,000
2016-08-10 3 PTGX Protagonist Therapeutics, Inc
Common Stock
263,952
2016-08-10 3 PTGX Protagonist Therapeutics, Inc
Common Stock
263,952
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)